Key points are not available for this paper at this time.
Abstract: Cardiovascular Diseases (CVDs) continue to be a leading cause of global morbidity and mortality, necessitating innovative approaches for early detection and personalized interventions. This research explores the transformative potential of machine learning (ML) in revolutionizing cardiovascular health. Leveraging advanced predictive analytics, our study employs a comprehensive dataset of cardiovascular parameters, incorporating clinical, genetic, and lifestyle factors. The machine learning model developed demonstrates remarkable accuracy in predicting the risk of heart disease, enabling early identification of individuals susceptible to CVD. This predictive analysis empowers healthcare professionals with a powerful tool for pre-emptive intervention and tailored treatment strategies. By considering individual variations in genetic predispositions, lifestyle choices, and clinical data, our approach moves beyond traditional risk assessment models, paving the way for a more personalized and effective healthcare paradigm. Furthermore, the integration of real-time monitoring devices and continuous data streams enhances the adaptability and responsiveness of our model. This allows for dynamic adjustments in treatment plans, ensuring ongoing optimization based on the evolving health status of each patient. The synergy between machine learning and cardiovascular health not only augments diagnostic precision but also facilitates a proactive healthcare ecosystem that prioritizes preventive measures.
Shilpy Agrawal (Thu,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: